Page last updated: 2024-08-22

yttrium and docetaxel anhydrous

yttrium has been researched along with docetaxel anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DeNardo, GL; DeNardo, SJ; Kukis, DL; Lamborn, KR; Meyers, FJ; Miers, LA; O'Donnell, RT	1

Other Studies

1 other study(ies) available for yttrium and docetaxel anhydrous

Article	Year
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. The Prostate, 2002, Jan-01, Volume: 50, Issue:1 Topics: Animals; Combined Modality Therapy; Docetaxel; Heterocyclic Compounds; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Paclitaxel; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioimmunotherapy; Taxoids; Transplantation, Heterologous; Yttrium	2002

Article

Year

Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.

The Prostate, 2002, Jan-01, Volume: 50, Issue:1

Topics: Animals; Combined Modality Therapy; Docetaxel; Heterocyclic Compounds; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Paclitaxel; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radioimmunotherapy; Taxoids; Transplantation, Heterologous; Yttrium

2002